There’s no question that UnitedHealth Group Inc. wishes its HMO subsidiaries had steered clear of Dr. Dipak Desai, a Nevada clinic owner who sparked a massive hepatitis C outbreak by reusing vials of the sedative propofol. But should UHG have to pay the price for including the criminally negligent doctor in its HMO provider networks?
That’s the billion-dollar question facing UHG in a trial now gearing up in state court in Las Vegas, as well as in an ongoing appeal of a previous blockbuster verdict. In hopes of persuading jurors to answer in the negative, the company tapped the powerhouse litigation boutique Bartlit Beck Herman Palenchar & Scott to lead its defense in the upcoming trial. And it recently roped in Hogan Lovells appellate whiz Neal Katyal to help overturn the earlier verdict, said to be the largest in Nevada state court history.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
